FTC Review Of CVS’ Eckerd Store Acquisition Extended
This article was originally published in The Pink Sheet Daily
CVS refiled its notice of intent to acquire a portion of the Eckerd drug store chain to allow Federal Trade Commission staff additional time for review, the company said May 14
You may also be interested in...
CVS sees the acquisition of Eckerd Health Services as key to luring larger corporate PBM customers. The acquisition of 1,260 Eckerd pharmacies also makes CVS the number one U.S. pharmacy retailer in store count, with over 5,000 outlets.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.